LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature …
Full LFMDP analysis →
Competitive advantage assessment
Key strengths
Scale Supporting ProfitabilityProfitability at scale is strong (score 0.77), demonstrating competitive advantages.
Operating Leverage in EffectOperating leverage is evident (score 0.84), with margins expanding over time.
Key risks
Revenue Volatility Signals Weak StickinessRevenue volatility is high (stability score 0.15), suggesting weak customer stickiness.
The dashed ring is the peer median. Defense scores are percentile ranks
against peers, so 50 is roughly the typical company in this group.
Upgrade to unlock the signals and evidence behind each defense.
Premium access
Unlock full defense analysis
Get key signals, strengths, and risks for every moat dimension.
LifeMD, Inc. - 8.875% Series A ranks #31 of 68
scored companies in Health Information Services by moat score — the top 46%.
The widest moat in the group is Veeva Systems Inc. (VEEV)
at 88/100.
Moat scores for companies ranked near LFMDP in Health Information Services
How LFMDP scores on the Corporate Default defenses
Pricing Power
Score 42
· 20% of the moat score
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Score 48
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Score 36
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 28
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 43
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Score 80
· 15% of the moat score
Scale matters only when it converts into economics.
What is LifeMD, Inc. - 8.875% Series A 's moat score?
LifeMD, Inc. - 8.875% Series A (LFMDP) scores 46 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #31 of 68 scored companies in Health Information Services, the top 46%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 67 companies in Health Information Services. Its strongest defense is Scale & Market Position (80/100) and its weakest is Capital Efficiency (28/100).
How does LifeMD, Inc. - 8.875% Series A compare with other Health Information Services companies?
LifeMD, Inc. - 8.875% Series A ranks #31 of 68 scored companies in Health Information Services by moat score. The widest moat in Health Information Services is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are LifeMD, Inc. (LFMD) at 47 just above it and Tempus AI, Inc. (TEM) at 44 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 67 companies in Health Information Services. The defenses are then weighted to produce the overall score out of 100.
Why is LifeMD, Inc. - 8.875% Series A scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for LifeMD, Inc. - 8.875% Series A ?
The Corporate Default template measures 6 defenses, and LFMDP scores: Pricing Power (42), Cost Advantage (48), Customer Stickiness (36), Capital Efficiency (28), Resilience (43), Scale & Market Position (80). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.